4,7-Methanoisobenzofuran-1,3-dione, 3a,4,7,7a-tetrahydro-5-methyl-, (3aα,4α,7α,7aα)-, reaction products with 2,2'-[1,6-hexanediylbis(oxymethylene)]bis[oxirane] (90431-86-0)
Identification |
Properties |
Safety Data |
|
|
Other Product
- 1,2-Cyclohexanedicarboxylic acid, bis(oxiranylmethyl) ester, reaction products with (3aα,4α,7α,7aα)-3a,4,7,7a-tetrahydro-5-methyl-4,7-methanoisobenzofuran-1,3-dione
- tert-butyl [2(S)-(3aα,4α,7α,7aα)]-[2-[(1,3,3a,4,7,7a-hexahydro-1,3-dioxo-4,7-methano-2H-isoindol-2-yl)oxy]-1-(hydroxymethyl)-2-oxoethyl]carbamate
- (1α,3aβ,4α,7α,8aβ)-hexahydro-1,4,10,10-tetramethyl-1H,4H,3a,8a-epoxy-4,7-methanoazulene
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-5(or 12)-methyl-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocinium iodide
- [2S-(2α,5α,6β)]-3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, compound with α-phenylbenzylamine
- 5-oxo-L-proline, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine (2:1)
- 5-ethyl-5-phenylbarbituric acid, compound with [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine
- Acetic acid, [(6-hydroxy-4-methyl-2-oxo-2H-1-benzopyran-7-yl)oxy]-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamid
- (1α,3α,4α,5β)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid, compound with 4-hydroxy-α-[1-[(1-methyl-2-phenoxyethyl)amino]ethyl]benzenemethanol (1:1)
- 5-oxo-L-proline, compound with [7(S)-(1α,2β,4β,5α,7β)]-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl α-(hydroxymethyl)benzeneacetate (1:1)
- 3-Cyclohexene-1-methanol, α,α,4-trimethyl-, hydroformylation products
- (1α,2β,4β,5α,7β)-()-9-methyl-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate hydrochloride
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]diazocine dihydroiodide
- [7S-(7α,7aα,14α,14aβ)]-dodecahydro-5,12-dimethyl-7,14-methano-2H,6H-dipyrido[1,2-a:1',2'-e][1,5]di(azocinium) diiodide
- 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-6-[[(5-methyl-3-phenyl-4-isoxazolyl)carbonyl]amino]-7-oxo-, [2S-(2α,5α,6β)]-, compd. with N,N'-bis(phenylmethyl)-1,2-ethanediamine (2:1)
- 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
- Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
- [7(S)-(1α,2β,4β,5α,7β)]-3-oxa-9-azatricyclo[3.3.1.02,4]non-7-yl (hydroxymethyl)phenylacetate
- 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 3-[[(aminocarbonyl)oxy]methyl]-7-methoxy-7-[[6-(methoxymethoxy)-5-[[(4-methylphenyl)sulfonyl]amino]-1,6-dioxohexyl]amino]-8-oxo-, methoxymethyl ester, [6R-[6α,7α,7(R*)]]-
- l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)